Neoclease

Neoclease is leveraging generative AI to design custom gene editors for individual therapeutic targets, beginning with an LRRK2-targeting editor for Parkinson’s disease. The venture aims to address the one-size-fits-all approach taken by conventional gene-editing tools, which often compromises precision, safety, and de

Neoclease is active in the advanced therapies space.

Profile

Neoclease is leveraging generative AI to design custom gene editors for individual therapeutic targets, beginning with an LRRK2-targeting editor for Parkinson’s disease. The venture aims to address the one-size-fits-all approach taken by conventional gene-editing tools, which often compromises precision, safety, and delivery. By rapidly generating and rigorously validating thousands of candidate editors in silico, Neoclease […]

As a business in advanced therapies, Neoclease is listed here with the public details available about it.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: www.neoclease.ai